article

Dextrorphan (DX) is a pharmacologically active metabolite of dextromethorphan (DM).

Chemistry


It is the result of O-demethylation of the prodrug by several enzymatic systems, although it is chiefly a product of the Cytochrome P450 IID6 (CYP4502D6) pathway.

Pharmacology


Being structurally similar to dextromethorphan, and it has affinity for the same receptors in the central nervous system but with a slight difference in selectivity.

Dextromethorphan is a weak non-competitive NMDA receptor antagonist but dextrorphan is a more potent antagonist*. DX is a strong anti-tussive, but is slightly less effective than DM, and has no metabolites with significant therapeutic activity in such capacity and therefore is not a drug available on the market.

Antagonism of the NDMA receptor is thought to impede the development of tolerance to opiates.

See also


Dekstrorfan

 

This article is licensed under the GNU Free Documentation License. It uses material from the "Dextrorphan".

Home Pageartsbusinesscomputersgameshealthhospitalshomekids & teensnewsphysiciansrecreationreferenceregionalscienceshoppingsocietysportsworld